{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T10:49:08Z","timestamp":1793270948858,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1124\/jpet.116.232884","type":"journal-article","created":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T03:29:01Z","timestamp":1469244541000},"page":"73-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Comparison of the \u03b2-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions"],"prefix":"10.1016","volume":"359","author":[{"given":"Shahrooz","family":"Nasrollahi-Shirazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Sucic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Freissmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Nanoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.116.232884_bib1","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1172\/JCI109781","article-title":"Elevation of \u03b2-adrenergic receptor density in human lymphocytes after propranolol administration","volume":"65","author":"Aarons","year":"1980","journal-title":"J Clin Invest"},{"key":"10.1124\/jpet.116.232884_bib2","doi-asserted-by":"crossref","first-page":"625","DOI":"10.7326\/0003-4819-81-5-625","article-title":"Coronary artery syndromes after sudden propranolol withdrawal","volume":"81","author":"Alderman","year":"1974","journal-title":"Ann Intern Med"},{"key":"10.1124\/jpet.116.232884_bib3","doi-asserted-by":"crossref","first-page":"11406","DOI":"10.1073\/pnas.1936664100","article-title":"\u03b2-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors","volume":"100","author":"Azzi","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.116.232884_bib4","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/jpet.116.232884_bib5","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/36362","article-title":"Switching of the coupling of the \u03b22-adrenergic receptor to different G proteins by protein kinase A","volume":"390","author":"Daaka","year":"1997","journal-title":"Nature"},{"key":"10.1124\/jpet.116.232884_bib6","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.bbalip.2012.01.005","article-title":"Vesicle-mediated ER export of proteins and lipids","volume":"1821","author":"Gillon","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/jpet.116.232884_bib7","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.2174\/138161210793292474","article-title":"Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors","volume":"16","author":"Gruber","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1124\/jpet.116.232884_bib8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S1053-0770(99)90007-1","article-title":"The safety and effectiveness of esmolol in the perioperative period in patients undergoing abdominal aortic surgery","volume":"13","author":"Harwood","year":"1999","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1124\/jpet.116.232884_bib9","doi-asserted-by":"crossref","first-page":"7559","DOI":"10.1021\/jm060642i","article-title":"Structure-brain exposure relationships","volume":"49","author":"Hitchcock","year":"2006","journal-title":"J Med Chem"},{"key":"10.1124\/jpet.116.232884_bib10","first-page":"536","article-title":"\u03b2 1-adrenoceptor subtype selective antagonism of esmolol and its major metabolite in vitro and in man. Investigations using tricresylphosphate as red blood cell carboxylesterase inhibitor","volume":"45","author":"Jahn","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"10.1124\/jpet.116.232884_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0076-6879(94)38005-8","article-title":"Determination of adenylyl cyclase catalytic activity using single and double column procedures","volume":"238","author":"Johnson","year":"1994","journal-title":"Methods Enzymol"},{"key":"10.1124\/jpet.116.232884_bib12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrd1875","article-title":"New concepts in drug discovery: collateral efficacy and permissive antagonism","volume":"4","author":"Kenakin","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/jpet.116.232884_bib13","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00210-002-0617-z","article-title":"Removal of the carboxy terminus of the A2A-adenosine receptor blunts constitutive activity: differential effect on cAMP accumulation and MAP kinase stimulation","volume":"366","author":"Klinger","year":"2002","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/jpet.116.232884_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11010-008-9929-8","article-title":"Prevalent role of Akt and ERK activation in cardioprotective effect of Ca(2+) channel- and \u03b2-adrenergic receptor blockers","volume":"321","author":"Kovacs","year":"2009","journal-title":"Mol Cell Biochem"},{"key":"10.1124\/jpet.116.232884_bib15","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1074\/jbc.M007910200","article-title":"Inhibition of adenylyl and guanylyl cyclase isoforms by the antiviral drug foscarnet","volume":"276","author":"Kudlacek","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.116.232884_bib16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.phrs.2014.01.005","article-title":"Pharmacological chaperoning: a primer on mechanism and pharmacology","volume":"83","author":"Leidenheimer","year":"2014","journal-title":"Pharmacol Res"},{"key":"10.1124\/jpet.116.232884_bib17","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1126\/science.1109237","article-title":"Transduction of receptor signals by \u03b2-arrestins","volume":"308","author":"Lefkowitz","year":"2005","journal-title":"Science"},{"key":"10.1124\/jpet.116.232884_bib18","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/01.CIR.0000127126.73759.23","article-title":"MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo","volume":"109","author":"Lips","year":"2004","journal-title":"Circulation"},{"key":"10.1124\/jpet.116.232884_bib19","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1124\/mol.110.063511","article-title":"Pharmacochaperoning of the A1 adenosine receptor is contingent on the endoplasmic reticulum","volume":"77","author":"M\u00e1laga-Di\u00e9guez","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.116.232884_bib20","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1213\/00000539-198503000-00005","article-title":"Cardiovascular effects of esmolol in anesthetized humans","volume":"64","author":"Menkhaus","year":"1985","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.116.232884_bib21","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJM197508282930902","article-title":"Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy","volume":"293","author":"Miller","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1124\/jpet.116.232884_bib22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/S0165-6147(00)01575-3","article-title":"Pharmacological chaperones: a new twist on receptor folding","volume":"21","author":"Morello","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.116.232884_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2133\/dmpk.20.337","article-title":"Pharmacokinetics and pharmacodynamics of landiolol hydrochloride, an ultra short-acting \u03b21-selective blocker, in a dose escalation regimen in healthy male volunteers","volume":"20","author":"Murakami","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/jpet.116.232884_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-94-007-4765-4_1","article-title":"ER-bound steps in the biosynthesis of G protein-coupled receptors","volume":"63","author":"Nanoff","year":"2012","journal-title":"Subcell Biochem"},{"key":"10.1124\/jpet.116.232884_bib25","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/00005344-198902000-00004","article-title":"A different desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of isoprenaline","volume":"13","author":"Nanoff","year":"1989","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/jpet.116.232884_bib26","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/00005344-199112000-00008","article-title":"Characterization of the beta-adrenoceptor blocking property of diprafenone in rats: stereoselective interaction, subtype specificity, and sensitization","volume":"18","author":"Nanoff","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/jpet.116.232884_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/BF01907017","article-title":"Desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of pindolol and celiprolol in rats","volume":"85","author":"Nanoff","year":"1990","journal-title":"Basic Res Cardiol"},{"key":"10.1124\/jpet.116.232884_bib28","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s40265-013-0077-4","article-title":"Landiolol: a review of its use in intraoperative and postoperative tachyarrhythmias","volume":"73","author":"Plosker","year":"2013","journal-title":"Drugs"},{"key":"10.1124\/jpet.116.232884_bib29","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","article-title":"Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale","volume":"90","author":"Rose","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1124\/jpet.116.232884_bib30","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1128\/MCB.18.2.790","article-title":"Activation of the mitogen-activated protein kinase\/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes","volume":"18","author":"Sch\u00f6nwasser","year":"1998","journal-title":"Mol Cell Biol"},{"key":"10.1124\/jpet.116.232884_bib31","doi-asserted-by":"crossref","first-page":"25833","DOI":"10.1074\/jbc.274.36.25833","article-title":"Activation of mitogen-activated protein kinase by the A(2A)-adenosine receptor via a rap1-dependent and via a p21(ras)-dependent pathway","volume":"274","author":"Seidel","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.116.232884_bib32","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.tips.2011.05.002","article-title":"\u03b2-Arrestin-mediated receptor trafficking and signal transduction","volume":"32","author":"Shenoy","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.116.232884_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/clpt.1983.193","article-title":"Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite","volume":"34","author":"Sum","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/jpet.116.232884_bib34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0962-8924(02)02294-8","article-title":"Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation","volume":"12","author":"Stork","year":"2002","journal-title":"Trends Cell Biol"},{"key":"10.1124\/jpet.116.232884_bib35","doi-asserted-by":"crossref","first-page":"16482","DOI":"10.1074\/jbc.M111.230037","article-title":"The serotonin transporter is an exclusive client of the coat protein complex II (COPII) component SEC24C","volume":"286","author":"Sucic","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.116.232884_bib36","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1074\/jbc.M112.408237","article-title":"Switching the clientele: a lysine residing in the C terminus of the serotonin transporter specifies its preference for the coat protein complex II component SEC24C","volume":"288","author":"Sucic","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/jpet.116.232884_bib37","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev.pa.36.040196.002333","article-title":"Complexity and diversity of mammalian adenylyl cyclases","volume":"36","author":"Sunahara","year":"1996","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/jpet.116.232884_bib38","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1210\/er.2013-1121","article-title":"Chaperoning G protein-coupled receptors: from cell biology to therapeutics","volume":"35","author":"Tao","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1124\/jpet.116.232884_bib39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.molmed.2010.11.004","article-title":"Therapeutic potential of \u03b2-arrestin- and G protein-biased agonists","volume":"17","author":"Whalen","year":"2011","journal-title":"Trends Mol Med"},{"key":"10.1124\/jpet.116.232884_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ncb2390","article-title":"COPII and the regulation of protein sorting in mammals","volume":"14","author":"Zanetti","year":"2011","journal-title":"Nat Cell Biol"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524194128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524194128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.116.232884","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:48:25Z","timestamp":1739994505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524194128"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0022356524194128"],"URL":"https:\/\/doi.org\/10.1124\/jpet.116.232884","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the \u03b2-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.116.232884","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}